Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments

NCT ID: NCT05829421

Last Updated: 2025-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-25

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate feasibility aspects of an intervention targeting problems in managing daily tasks due to mild-to-moderate poststroke cognitive impairments. We will specifically address uncertainties related to intervention content and delivery, and trial design and conduct.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Impairment Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Feasibility study, non-randomised. An adaptive approach will be used to optimise the intervention content and study conduct as feasibility data are cumulated
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Impairment-specific occupational therapy (OT) intervention

Patients receive an impairment-specific OT intervention targetting problems in managing activities of daily living (ADL) due to mild-to-moderate poststroke cognitive impairments. The intervention is initiated in the stroke unit as soon as patients' medical condition allows it, and it is delivered 3 times per week until 3 months poststroke. After hospital discharge, the intervention continues in community settings.

Group Type EXPERIMENTAL

Impairment-specific occupational therapy (OT) intervention

Intervention Type OTHER

In parallel with standard practice, patients receive an OT intervention adapted to the specific underlying cognitive impairments that are likely to disturb their performance of ADLs.

The intervention is individualised through a 3-step process: a) a list of dysfunctional ADL process skills is forwarded by the OT to the neuropsychologist (NP), b) the NP identifies the cognitive impairments which are most likely to cause the dysfunctional ADL process skills through a cognitive assessment, c) based on the identified cognitive impairments, the NP and the OT select in collaboration the cognitive strategies that are most likely to benefit the individual patient from a pre-prepared intervention manual. Because of the large heterogeneity in how cognitive impairments impact on ADL performance, the exact way of implementing the selected cognitive strategies into the practice of the individual patient is left to the OT´s clinical judgement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Impairment-specific occupational therapy (OT) intervention

In parallel with standard practice, patients receive an OT intervention adapted to the specific underlying cognitive impairments that are likely to disturb their performance of ADLs.

The intervention is individualised through a 3-step process: a) a list of dysfunctional ADL process skills is forwarded by the OT to the neuropsychologist (NP), b) the NP identifies the cognitive impairments which are most likely to cause the dysfunctional ADL process skills through a cognitive assessment, c) based on the identified cognitive impairments, the NP and the OT select in collaboration the cognitive strategies that are most likely to benefit the individual patient from a pre-prepared intervention manual. Because of the large heterogeneity in how cognitive impairments impact on ADL performance, the exact way of implementing the selected cognitive strategies into the practice of the individual patient is left to the OT´s clinical judgement.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* first-ever symptomatic stroke,
* age ≥ 18 years,
* residence in Frederiksberg Municipality, Denmark,
* independent in pre-stroke everyday life (≤ 2 points on the modified Rankin Scale, mRS),
* experiencing problems in performing ADLs due to cognitive impairment; these problems are expected to still be present at hospital discharge,
* medical condition allows commencement of rehabilitation focused on ADL and cognition
* fully aware or mild-to-moderate unawareness of deficits (≤ 2 points on the Bisiach Anosognosia Scale, BAS),
* a global cognitive function corresponding to ≥ 17 points on the Montreal Cognitive Assessment, MoCA,
* ≤ 10 points on the depression subscale of the Hospital Anxiety and Depression Scale, HADS,
* able to provide informed consent, as evaluated by the recruiting healthcare professional(s),
* logistically possible to perform baseline assessments and create an individualised intervention plan during hospital stay
* provides informed consent


* appointed as close carer (by a patient who consented to participate),
* age ≥18y,
* provides informed consent.


* appointed as local project managers, or OTs or NPs who conduct assessments or deliver the intervention in the participating centres,
* provides informed consent.

Exclusion Criteria

* psychiatric conditions causing difficulties or preventing participation, as evaluated by the recruiting health care professional(s)
* communication problems causing difficulties or preventing participation, as evaluated by the recruiting healthcare professional(s)

CAREGIVERS:


-communication problems or other issues causing difficulties in participation as evaluated by the recruiting healthcare professional(s).

Patients without a close carer will not be excluded.

CLINICAL STAFF:


\- unable to to follow a preliminary English version of the intervention manual.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rigshospitalet, Denmark

OTHER

Sponsor Role collaborator

The Day Rehabilitation Centre, Frederiksberg Municipality, Denmark

UNKNOWN

Sponsor Role collaborator

The Inpatient Rehabilitation Centre, Frederiksberg Municipality, Denmark

UNKNOWN

Sponsor Role collaborator

Neurorehabilitation Centre Østervang, Frederiksberg Municipality, Denmark

UNKNOWN

Sponsor Role collaborator

Emma Ghaziani

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emma Ghaziani

Postdoc, OT

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hanne Christensen, Professor

Role: PRINCIPAL_INVESTIGATOR

Bispebjerg and Frederiksberg Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bispebjerg and Frederiksberg Hospital

Copenhagen, , Denmark

Site Status

Neurorehabilitation Centre Østervang

Frederiksberg, , Denmark

Site Status

the Day Rehabilitation Centre

Frederiksberg, , Denmark

Site Status

the Inpatient Rehabilitation Centre

Frederiksberg, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-22066840

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.